Tapewire

NYSE · USD

MD

Pediatrix Medical Group, Inc.

Export transactions ↓
Tapewire entity
4451
SEC CIK
0000893949
Parsed reports
309

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 22, 2018 Filed May 23, 2018 20:56 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionCommon Stock 3,000 $27.72 $83,145.00
Disclosure

SEC source: 0001209191-18-032649 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2018 Filed May 23, 2018 20:55 UTC
Lopez-Blanco VivianChief Financial Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 40,000 $25.14 Strike: $25.14 $1,005,600.00
Disclosure

SEC source: 0001209191-18-032648 · doc4.xml · derivative · entry 3

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2018-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2018 Filed May 23, 2018 20:55 UTC
Lopez-Blanco VivianChief Financial Officer
Tax withholdingCommon Stock 26,058 $46.60 $1,214,302.80
Disclosure

SEC source: 0001209191-18-032648 · doc4.xml · nonDerivative · entry 2

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,927.24

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 13,942 shares of common stock upon the net exercise of 40,000 stock options with 26,058 shares withheld for payment of the exercise price and taxes, based on the market price of Issuer's common stock at the time of the option exercise.

Read SEC document
May 21, 2018 Filed May 23, 2018 20:55 UTC
Lopez-Blanco VivianChief Financial Officer
Exercise / conversionCommon Stock 40,000 $25.14 $1,005,600.00
Disclosure

SEC source: 0001209191-18-032648 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,985.24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2018 Filed May 8, 2018 21:01 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 10,668 $27.72 Strike: $27.72 $295,663.62
Disclosure

SEC source: 0001209191-18-028634 · doc4.xml · derivative · entry 3

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2018-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: Stock Options were due to expire on May 23, 2018.

Read SEC document
May 04, 2018 Filed May 8, 2018 21:01 UTC Tax withholdingCommon Stock 6,578 $44.95 $295,681.10
Disclosure

SEC source: 0001209191-18-028634 · doc4.xml · nonDerivative · entry 2

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,987

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 4,090 shares of common stock upon the net exercise of 10,668 stock options with 6,578 shares withheld for payment of the exercise price, based on the market price of Issuer's common stock at the time of the option exercise.

Read SEC document
May 04, 2018 Filed May 8, 2018 21:01 UTC Exercise / conversionCommon Stock 10,668 $27.72 $295,663.62
Disclosure

SEC source: 0001209191-18-028634 · doc4.xml · nonDerivative · entry 1

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 19, 2018 Filed Mar 20, 2018 20:36 UTC
SOSA ENRIQUEDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 10,668 $27.72 Strike: $27.72 $295,663.62
Disclosure

SEC source: 0001209191-18-020883 · doc4.xml · derivative · entry 3

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2018-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 19, 2018 Filed Mar 20, 2018 20:36 UTC
SOSA ENRIQUEDirector
Tax withholdingCommon Stock 5,259 $56.23 $295,713.57
Disclosure

SEC source: 0001209191-18-020883 · doc4.xml · nonDerivative · entry 2

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,306

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 5,409 shares of common stock upon the net exercise of 10,668 stock options with 5,259 shares withheld for payment of the exercise price, based on the market price of Issuer's common stock at the time of the option exercise.

Read SEC document
March 19, 2018 Filed Mar 20, 2018 20:36 UTC
SOSA ENRIQUEDirector
Exercise / conversionCommon Stock 10,668 $27.72 $295,663.62
Disclosure

SEC source: 0001209191-18-020883 · doc4.xml · nonDerivative · entry 1

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2018 Filed Mar 14, 2018 21:05 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 3,000 $27.72 Strike: $27.72 $83,145.00
Disclosure

SEC source: 0001209191-18-019619 · doc4.xml · derivative · entry 3

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2018-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2018 Filed Mar 14, 2018 21:05 UTC
Pepia John CPrincipal Accounting Officer
SaleCommon Stock 3,000 $58.35 $175,062.60
Disclosure

SEC source: 0001209191-18-019619 · doc4.xml · nonDerivative · entry 2

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,716

F1 · kind: Sales made pursuant to Reporting Person's 105b-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $57.85 to $58.79 for a weighted average sales price of $58.3542. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares at each separate price within the range set forth in this footnote.

Read SEC document
March 13, 2018 Filed Mar 14, 2018 21:05 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionCommon Stock 3,000 $27.72 $83,145.00
Disclosure

SEC source: 0001209191-18-019619 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:07 UTC
SOSA ENRIQUEDirector
GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015799 · doc4.xml · nonDerivative · entry 1

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,897

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:06 UTC
MEDEL ROGER MDDirector · Chief Executive Officer
GrantCommon Stock 147,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015794 · doc4.xml · nonDerivative · entry 1

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,436,178

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 36,860 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:07 UTC GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015798 · doc4.xml · nonDerivative · entry 1

SHALALA DONNA E · CIK 0001140422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,947

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:06 UTC
Pepia John CPrincipal Accounting Officer
GrantCommon Stock 4,147 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015797 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,716

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance-based criteria with any shares earned vesting in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:05 UTC
Lopez-Blanco VivianChief Financial Officer
GrantCommon Stock 36,860 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015793 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,985.24

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 9,215 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:02 UTC
Kadre ManuelDirector
GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015786 · doc4.xml · nonDerivative · entry 1

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,897

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:01 UTC GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015784 · doc4.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,422

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:01 UTC
GABOS PAUL GDirector
GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015782 · doc4.xml · nonDerivative · entry 1

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,897

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:00 UTC GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015780 · doc4.xml · nonDerivative · entry 1

FERNANDEZ MICHAEL · CIK 0001218838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,589

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 22:00 UTC
Clark David A.Pres. Mednax Natl Med Group
GrantCommon Stock 19,352 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015777 · doc4.xml · nonDerivative · entry 1

Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,452

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 4,838 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:59 UTC GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015774 · doc4.xml · nonDerivative · entry 1

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,897

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:59 UTC
CALABRO JOSEPH MPresident and COO
GrantCommon Stock 92,149 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015773 · doc4.xml · nonDerivative · entry 1

CALABRO JOSEPH M · CIK 0001218834 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,933

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 23,037 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:59 UTC GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015772 · doc4.xml · nonDerivative · entry 1

Barker Karey D · CIK 0001641573 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,362

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:58 UTC
Andreano Dominic JSVP, General Counsel and Secy
GrantCommon Stock 13,823 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015769 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,039.22

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 3,456 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:57 UTC GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015766 · doc4.xml · nonDerivative · entry 1

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,897

F1 · acquired: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
December 12, 2017 Filed Dec 12, 2017 21:48 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 3,000 $27.72 Strike: $27.72 $83,145.00
Disclosure

SEC source: 0001209191-17-065215 · doc4.xml · derivative · entry 3

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 3,000 shares

Expires 2018-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2017 Filed Dec 12, 2017 21:48 UTC
Pepia John CPrincipal Accounting Officer
SaleCommon Stock 3,000 $51.58 $154,740.00
Disclosure

SEC source: 0001209191-17-065215 · doc4.xml · nonDerivative · entry 2

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

Read SEC document
December 12, 2017 Filed Dec 12, 2017 21:48 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionCommon Stock 3,000 $27.72 $83,145.00
Disclosure

SEC source: 0001209191-17-065215 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 22:35 UTC
Clark David A.Pres. Mednax Natl Med Group
GrantRestricted Shares Units · Derivative 14,741 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-064791 · doc4.xml · derivative · entry 1

Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,741

Underlying: Common Stock · 14,741 shares

Expires 2020-05-15

F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended.

F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock.

F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 22:36 UTC
Andreano Dominic JSVP, General Counsel and Secy
GrantRestricted Shares Units · Derivative 9,828 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-064792 · doc4.xml · derivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,828

Underlying: Common Stock · 9,828 shares

Expires 2020-05-15

F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended.

F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock.

F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 22:34 UTC
Pepia John CPrincipal Accounting Officer
GrantRestricted Shares Units · Derivative 7,862 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-064790 · doc4.xml · derivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,862

Underlying: Common Stock · 7,862 shares

Expires 2020-05-15

F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended.

F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock.

F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria.

Read SEC document
November 03, 2017 Filed Nov 3, 2017 20:44 UTC SaleCommon Stock 10,668 $42.59 $454,374.66
Disclosure

SEC source: 0001209191-17-059188 · doc4.xml · nonDerivative · entry 2

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,547

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-nine (29) separate transactions with prices ranging from $42.35 to $42.81 for an average weighted sales price of $42.5923. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:44 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 10,668 $32.33 Strike: $32.33 $344,843.10
Disclosure

SEC source: 0001209191-17-059188 · doc4.xml · derivative · entry 3

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2017-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:44 UTC Exercise / conversionCommon Stock 10,668 $32.33 $344,843.10
Disclosure

SEC source: 0001209191-17-059188 · doc4.xml · nonDerivative · entry 1

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,215

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 12, 2017 Filed Sep 13, 2017 21:11 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 3,000 $27.72 Strike: $27.72 $83,145.00
Disclosure

SEC source: 0001209191-17-052647 · doc4.xml · derivative · entry 3

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 3,000 shares

Expires 2018-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 12, 2017 Filed Sep 13, 2017 21:11 UTC
Pepia John CPrincipal Accounting Officer
SaleCommon Stock 3,000 $42.85 $128,550.00
Disclosure

SEC source: 0001209191-17-052647 · doc4.xml · nonDerivative · entry 2

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

Read SEC document
September 12, 2017 Filed Sep 13, 2017 21:11 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionCommon Stock 3,000 $27.72 $83,145.00
Disclosure

SEC source: 0001209191-17-052647 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 14, 2017 Filed Jun 14, 2017 20:51 UTC SaleCommon Stock 1,969 $57.57 $113,355.33
Disclosure

SEC source: 0001209191-17-039857 · doc4.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,072

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:45 UTC
SOSA ENRIQUEDirector
GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037329 · doc4.xml · nonDerivative · entry 1

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,547

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:44 UTC
Pepia John CPrincipal Accounting Officer
GrantCommon Stock 4,044 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037325 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:44 UTC GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037326 · doc4.xml · nonDerivative · entry 1

SHALALA DONNA E · CIK 0001140422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,597

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:43 UTC
MEDEL ROGER MDDirector · Chief Executive Officer
Tax withholdingCommon Stock 38,257 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037322 · doc4.xml · nonDerivative · entry 3

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,288,739

F3 · balance_after: Reflects a reduction of 16,840 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:43 UTC
MEDEL ROGER MDDirector · Chief Executive Officer
GrantCommon Stock 110,532 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037322 · doc4.xml · nonDerivative · entry 2

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,343,836

F2 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restate 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 27,633 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:42 UTC
Lopez-Blanco VivianChief Financial Officer
GrantCommon Stock 23,365 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037318 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,125.24

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 5,841 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

F2 · balance_after: Reflects a reduction of 3,559 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:42 UTC
Kadre ManuelDirector
GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037315 · doc4.xml · nonDerivative · entry 1

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,547

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:41 UTC GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037312 · doc4.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,041

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:41 UTC
GABOS PAUL GDirector
GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037306 · doc4.xml · nonDerivative · entry 1

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,547

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.